Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase

11 clinical trials · Condition

Sort:Newest first Oldest first

◉ Watch Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase

Record	Firm	Date
Elotuzumab for the Treatment of JAK2-Mutated Myelofibrosis (NCT04517851)	M.D. Anderson Cancer Center	2021-02-10
PAT-1251 in Treating Patients With Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocytosis Myelofibrosis (NCT04054245)	M.D. Anderson Cancer Center	2019-07-24
Azacitidine, Venetoclax, and Pevonedistat in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia (NCT03862157)	M.D. Anderson Cancer Center	2019-02-27
Durvalumab in Treating Patients With Primary, Post-Polycythemia Vera, or Post-Essential Thrombocythemia Myelofibrosis (NCT02871323)	Northwestern University	2016-11-01
Nivolumab in Treating Patients With Primary Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis, or Post-Polycythemia Vera Myelofibrosis (NCT02421354)	M.D. Anderson Cancer Center	2015-05-14
LCL161 in Treating Patients With Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocytosis Myelofibrosis (NCT02098161)	M.D. Anderson Cancer Center	2014-12-18
Ruxolitinib Phosphate and Azacytidine in Treating Patients With Myelofibrosis or Myelodysplastic Syndrome/Myeloproliferative Neoplasm (NCT01787487)	M.D. Anderson Cancer Center	2013-03-13
Anti-TGF-beta Therapy in Patients With Myelofibrosis (NCT01291784)	John Mascarenhas	2011-02-01
LBH589 (Panobinostat) for the Treatment of Myelofibrosis (NCT01298934)	Ronald Hoffman	2009-09-01
Fludarabine Phosphate and Total Body Irradiation Followed by a Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndromes or Myeloproliferative Disorders (NCT00397813)	Fred Hutchinson Cancer Center	2006-01-01

Track Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase automatically

Every clearance here is in the API, with alerts when new ones post.